Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: More from Stan Caplan

With the '336 NIRC, PDSG moving forward, action on the other patents, revenue potential increasing, the price is going to improve anyway.

I look forward to reading what will be done over and above this to increase shareholder value, as there surely can't be claims of succees for that which is already in motion, can there?

.

.

.

Be well

Share
New Message
Please login to post a reply